The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Shannon John Patrick Jr since 2014.
This trader's CIK number is 1553595.
At the time of last reporting, Shannon John Patrick Jr was the See Remarks of Xeris Biopharma Holdings, Inc.. (stock ticker symbol XERS).
Also see all insider trading activities at Xeris Biopharma Holdings, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2020 | XERS | 41,934 | $153,208 | 0 | $0 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2023 | XERS | 30,769 | $50,399 | 0 | $0 | 0 | $0 |
| 2021 | XERS | 100,000 | $209,520 | 0 | $0 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2014 | DRTX | 3,000 | $41,160 | 0 | $0 | 0 | $0 |
1. Xeris Pharmaceuticals Inc (XERS)
2. Xeris Biopharma Holdings, Inc. (XERS)
3. Durata Therapeutics, Inc. (DRTX)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2020-05-13 | XERS | Buy | 22,000 | 3.54 | 77,990 |
| 2020-05-08 | XERS | Buy | 7,886 | 3.20 | 25,219 |
| 2020-02-14 | XERS | Buy | 12,048 | 4.15 | 49,999 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-11-17 | XERS | Buy | 30,769 | 1.64 | 50,399 |
| 2021-11-12 | XERS | Buy | 60,000 | 2.10 | 126,000 |
| 2021-11-11 | XERS | Buy | 40,000 | 2.09 | 83,520 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2014-08-12 | DRTX | Buy | 3,000 | 13.72 | 41,160 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Shannon John Patrick Jr (See Remarks of Xeris Biopharma Holdings, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.